The AAViator™ Production Platform: Up To 9X Higher Titers In Small-Cell Culture Systems And Bench-Scale Bioreactors

Gene therapy developers face mounting pressure to deliver high-quality vectors quickly and cost-effectively. The AAViator™ Production Platform offers a streamlined approach to both process development and vector manufacturing to help teams accelerate timelines without compromising product integrity. By integrating key steps and reducing complexity, the platform supports faster scale-up and more predictable outcomes, which are critical advantages in a competitive and fast-moving therapeutic landscape. Whether you're optimizing early-stage development or preparing for clinical production, this solution is designed to reduce bottlenecks and improve consistency.

Explore how the AAViator™ platform can help you meet your goals with greater speed and confidence.